BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1736312)

  • 1. J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.
    Randall TD; Parkhouse RM; Corley RB
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):962-6. PubMed ID: 1736312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence that J chain regulates the polymeric structure of IgM in antibody-secreting B cells.
    Randall TD; Brewer JW; Corley RB
    J Biol Chem; 1992 Sep; 267(25):18002-7. PubMed ID: 1517233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological effects of IgM hexamer formation.
    Randall TD; King LB; Corley RB
    Eur J Immunol; 1990 Sep; 20(9):1971-9. PubMed ID: 2120070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12.
    Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y
    J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell response pathways regulated by IL-5 and IL-2. Secretory microH chain-mRNA and J chain mRNA expression are separately controlled events.
    Matsui K; Nakanishi K; Cohen DI; Hada T; Furuyama J; Hamaoka T; Higashino K
    J Immunol; 1989 Apr; 142(8):2918-23. PubMed ID: 2495329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional analysis of J chain-deficient IgM.
    Wiersma EJ; Collins C; Fazel S; Shulman MJ
    J Immunol; 1998 Jun; 160(12):5979-89. PubMed ID: 9637512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 and IL-5 both induce mu S and J chain mRNA in a clonal B cell line, but differ in their cell-cycle dependency for optimal signaling.
    Takayasu H; Brooks KH
    Cell Immunol; 1991 Sep; 136(2):472-85. PubMed ID: 1831408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of IgM secretion and H chain mRNA expression in CH12.LX.C4.5F5 B cells by adrenocorticotropic hormone.
    Bost KL; Clarke BL; Xu JC; Kiyono H; McGhee JR; Pascual D
    J Immunol; 1990 Dec; 145(12):4326-31. PubMed ID: 2175328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes.
    Schliephake DE; Schimpl A
    Eur J Immunol; 1996 Jan; 26(1):268-71. PubMed ID: 8566078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer IgM assembly and secretion in lymphoid and nonlymphoid cell lines: evidence that J chain is required for pentamer IgM synthesis.
    Niles MJ; Matsuuchi L; Koshland ME
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2884-8. PubMed ID: 7708742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in J chain and mu chain RNA expression as a function of B cell differentiation.
    Lamson G; Koshland ME
    J Exp Med; 1984 Sep; 160(3):877-92. PubMed ID: 6206193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM.
    Hughey CT; Brewer JW; Colosia AD; Rosse WF; Corley RB
    J Immunol; 1998 Oct; 161(8):4091-7. PubMed ID: 9780180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immunoglobulin gene expression in normal lymphocytes. II. Mechanisms of down-regulation of immunoglobulin secretion after engagement of the B cell antigen receptor.
    Berberich I; Schimpl A
    Eur J Immunol; 1992 Feb; 22(2):525-9. PubMed ID: 1537386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures.
    Chen-Bettecken U; Wecker E; Schimpl A
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7384-8. PubMed ID: 3933005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity.
    Oskam N; Ooijevaar-de Heer P; Derksen NIL; Kruithof S; de Taeye SW; Vidarsson G; Reijm S; Kissel T; Toes REM; Rispens T
    J Immunol; 2022 Jul; 209(1):16-25. PubMed ID: 35705253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain.
    Davis AC; Roux KH; Pursey J; Shulman MJ
    EMBO J; 1989 Sep; 8(9):2519-26. PubMed ID: 2511005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for incorporation of J chain into human IgM and IgA.
    Sørensen V; Rasmussen IB; Sundvold V; Michaelsen TE; Sandlie I
    Int Immunol; 2000 Jan; 12(1):19-27. PubMed ID: 10607746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production.
    Pascual DW; Xu-Amano JC; Kiyono H; McGhee JR; Bost KL
    J Immunol; 1991 Apr; 146(7):2130-6. PubMed ID: 1706387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain.
    Cattaneo A; Neuberger MS
    EMBO J; 1987 Sep; 6(9):2753-8. PubMed ID: 3119328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of IgM structures involved in J chain incorporation.
    Wiersma EJ; Chen F; Bazin R; Collins C; Painter RH; Lemieux R; Shulman MJ
    J Immunol; 1997 Feb; 158(4):1719-26. PubMed ID: 9029108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.